MedMen, a California-based cannabis management and consulting firm, has acquired Bloomfield Industries, a financially troubled New York  business license holder that in recent months has been unable to pay vendors and has been casting for new investors, according to to Politico.

A New York Health Department spokeswoman emphasized that Bloomfield would not be transferring its license to MedMen, a move that is prohibited under state cannabis business laws. She instead described the transaction as a change in ownership, which is permitted if approved by the health department.

Bloomfield Industries is one of five licensed medical cannabis companies in New York that launched programs a year ago.

MedMen is partnered with Wicklow Capital, a Chicago-based family office that helped the firm launch a $100 million canna-centric private equity fund. Wicklow, however, is already the primary investor in PharmaCann, another of New York’s five licensed cannabis businesses.

Despite the ownership change, MedMen must keep intact Bloomfield’s operating plan, including providing the same merchandise, and conduct business as Bloomfield Industries until its two-year registration expires July 31. The new owners also must use the same pricing system as Bloomfield and use the same facilities.